Skip to main content

HLA-Restriction of Human Treg Cells Is Not Required for Therapeutic Efficacy of Low-Dose IL-2

Jeremy A. Goettel, Ph.D., Assistant Professor of Medicine at Vanderbilt University Medical Center, Division of Gastroenterology, presented the latest research demonstrating the utility of standard immune humanized NSG mice as a pre-clinical model system to evaluate therapeutics targeting human Treg cells to treat IBD. (Recorded on November 30, 2021) Full presentation title: HLA-Restriction of Human Treg Cells Is Not Required for Therapeutic Efficacy of Low-Dose IL-2 in Humanized Mice